Katrin Strassburg, 1,2 Billy Joe Molloy, 5 Claude Mallet, 3 André Duesterloh, 4 Igor Bendik, 4 Thomas Hankemeier, 1,2 James Langridge, 5 Rob J. Vreeke

HILIC UPLC/MS UPLC LC/ MS LC/MS HPLC 2-4 HPLC 4,5 HILIC / HILIC 80 ACQUITY UPLC Xevo QTof MS ACQUITY BEH HILIC HILIC TOF ESI 1.7 µm BEH HILIC UPLC HIL

HILIC UPLC/MS UPLC LC/ MS LC/MS HPLC 2-4 HPLC 4,5 HILIC / HILIC 80 ACQUITY UPLC Xevo QTof MS ACQUITY BEH HILIC HILIC TOF ESI 1.7 µm BEH HILIC UPLC HILIC UPLC HPLC 1 100 µl 900 µl 15 900 µl 500 µl 470 µl

Sigma-Aldrich (Poole,Dorset,UK) LGC Standards(Teddington,Surrey,UK) 1 mg/ml Sigma-Aldrich Greyhound Chromatography(Brikenhead,UK) / Waters ACQUITY UPL

ACQUITY UPLC I-Class/Xevo TQD Mark Roberts and Michelle Wood Waters Corporation, MS Technologies Centre, Manchester, UK ACQUITY UPLC I-Class/Xevo TQD 2 2 MRM 178 / 950 MS ACQUITY UPLC/ACQUITY TQD 2 1-3

LC LC ACQUITY UPLC H-Class ACQUITY UPLC CSH C mm 1.7 µm : THF/ 2/8 A 1 mm / 4/6 THF 2 mg/ml THF/ 2 THF 2 ACQUITY UPLC CSH C 18

ACQUITY UPLC H-Class/QDa Nihon Waters K.K., Tokyo, Japan TAG 1 3 1 1 8 9 TAG TAG TAG TAG TAG UV UV APCI ESI MS TAG Sn-2 Sn-3 Sn-1 C18: ACQUITY UPLC CSH C 18 ACQUITY UPLC H-Class 1. ACQUITY QDa TAG ACQUITY

Waters Sigma-Aldrich 1.0 mg/ml LC Waters Alliance HPLC ACQUITY UPLC H-Class Bio 30 cm Alliance HPLC UV ACQUITY UPLC TUV mm nm XBridge Protein B

HPLC 3. µm BEH Stephan Koza, Susan Serpa, Hua Yang, Edouard Bouvier, and Kenneth J. Fountain Waters Corporation, Milford, MA, USA HPLC 200 0 HPLC 2 2010 UPLC 200 SEC 1 UPLC SE-UPLC 2 µm BEH BEH 100% SE-UPLC

LC ACQUITY UPLC H-Class Bio TUV Sigma, mg/ml 0.01 N 276 nm μl 0.4 ml/min L g/l / 99% / 65/15/20 v/v/v 10% 10% 0.01 N ACQUITY

Ultra Performance Liquid Chromatography Stephan Koza, Paula Hong, and Kenneth J. Fountain Waters Corporation, 34 Maple Street, Milford, MA, USA & SEC 2010 2 8 5 2030 4 3 8 1982 2009 131 USP EPHMW USP34

ACQUITY UPC 2 ACQUITY UPC 2 A A+D3 D ml E 10 ml K μm K μm PDA ACQUITY UPC 2 BEH mm, 1.7 μm ACQUITY UPC 2 HSS C 18 SB 3.

UPC 2 Andrew Aubin Waters Corporation, Milford, MA, USA Waters ACQUITY UPC 2TM 6 tert- UltraPerformance Convergence Chromatography TM UPC 2 ACQUITY UPC 2 1 A A D3 E D3 K1 K2 UPC 2 A E K1 ACQUITY UPC 2

[ OASIS SAMPLE-EXTRACTION PRODUCTS ] LC-MS HPLC UPLC 1

Simplify Sample Preparation [ SAMPLE PREPARATION SOLUTIONS ] [ OASIS SAMPLE-EXTRACTION PRODUCTS ] LC-MS HPLC UPLC 1 [ SAMPLE PREPARATION SOLUTIONS ] [ OASIS SAMPLE-EXTRACTION PRODUCTS ] 2 [ OASIS SAMPLE-EXTRACTION

1 WSV SIR m/z Analyte RT (Min) SIR m/z Cone voltage (V) Ascorbic Acid (C).91 177 2 Thiamine (B1) 1.1 265 5 Nicotinic Acid (B3) 1.27 124 15 Pyridoxal (

ACQUITY UPLC H-Class ACQUITY QDa Mark E. Benvenuti, Dimple Shah, and Jennifer A. Burgess Waters Corporation, Milford, MA, USA MS ACQUITY QDa UPLC HPLC UV ACQUITY QDa LC EC 1925/26 CFR 21 HPLC 1 LC-MS ACQUITY

2D-UPLC/MS Catalin Doneanu, Keith Fadgen, StJohn Skilton, Martha Stapels, and Weibin Chen Waters Corporation, Milford, MA, U.S. 4 5 HCP UPLC/MS E HCP

2D-UPLC/MS Catalin Doneanu, Keith Fadgen, StJohn Skilton, Martha Stapels, and Weibin Chen Waters Corporation, Milford, MA, U.S. 4 5 HCP UPLC/MS E HCP DNA 1 100 ppm HCPHCP HCP HCP 2008 EMA HCP 1 2006 HCP

low_ JAJP.qxd

LC/MS Chad Borges, Matthew Slawson, James Taccogno, and Dennis Crouch Center for uman Toxicology University of Utah Salt Lake City, UT USA John M. ughes Agilent Technologies, Inc. Pleasanton, CA USA (oa-tof)

UPC 2 Baiba Cabovska, Michael D. Jones, and Andrew Aubin Waters Corporation, Milford, MA, USA UPC 2 ACQUITY UPC 2TM ACQUITY SQD Empower 3 UPC GC

UPC 2 Baiba Cabovska, Michael D. Jones, and Andrew Aubin Waters Corporation, Milford, MA, USA UPC 2 ACQUITY UPC 2TM ACQUITY SQD Empower 3 UPC 2 1-3 GC LC GC UltraPerformance Convergence Chromatography

MS Xevo G2 Q-Tof ESI+ 1 2 / pm-4 00 am 2 00 am # am # am #3 / pm am am #4 0.8 kv 20 V MS E ev MS E MASSLYNX

UPLC-Tof-MS E John Archer, 1 Paul Dargan, 1 David Wood, 1 Nayan Mistry, 2 and Michelle Wood 2 1 Guy s and St. Thomas NHS Foundation Trust, Clinical Toxicology, London, UK 2 Waters Corporation, MS Technologies

1.2 M N M d- BBB / ChE etc ChE etc CCh BCh etc Ach ChE 2 Ach ChE PAM ChE

1 - d- etc etc d-tc ChE > < < < > > > or 1.1 1 d- < dtc Na + Na + I II ChE ChE ChE ( ) T Ca++ 1 Na + K + Na + Ach Ach Ach BTX Mg 2+ Ach CAT TTX Ach 1.2 M N M d- BBB / ChE etc ChE etc CCh BCh etc Ach ChE

LCMS14003:UHPLC-Orbitrap質量分析計による環境汚染物質のターゲット分析、ノンターゲット分析

UHPLC Orbitrap Application Note LCMS14003 Orbitrap CEC CEC 61 CEC 312 CEC SPE UHPLCThermo Scientifi c Orbitrap Thermo Scientifi c TraceFinder WWTP S1 PS 5 ºC S2 TWAS 5 ºC 1 WWTP 1 2 WWTP 2 1 2 S1 1 S2

untitled

Frank David Research Institute for Chromatography President Kennedy Park B- Kortrijk, Belgium Pat Sandra University of Gent Krijgslaan 281 S4, B-9000 Gent Belgium Allen K. Vickers Agilent Technologies,

☆H23 13－農薬一斉分析（大垣）.doc

13 56 2011 Examination of Determination of Residual Pesticides in Agricultural Products Yuki OHGAKI, Katsuhiro HAYASHI, Hiroyuki KAWAI, and Kyoko SHIMURA GC/MS 92 LC/MS/MS 60 150 n- 5 GC/MS 92 79 70% LC/MS/MS

平成26年度 化学物質分析法開発報告書

2,2-2,2 -Iminodiethanol Diethanol amine CAS 111-42-2 C 4 H 11 NO 2 105.1356-105.0790-28 C 1) 1.0881 g/cm 3 1)

外因性内分泌攪乱化学物質調査暫定マニュアル（水質、底質、水生生物）

p,p -DDT p,p -DDE p,p -DDD trans- cis- trans- cis- (PBB) (BaP) 25ng/L 5µg/kg GC/MS-SIM GC/MS-SIM GC/MS-SIM GC/MS-SIM (2-, 3-, 4- ) (4,4'- ) p,p'-ddt- 13 C 12 HCB- 13 C 6 BaP-d 12 -d10 -d 10 p- -d 14 1000

平成26年度 化学物質分析法開発報告書

2,2-2,2 -Iminodiethanol Diethanol amine CAS 111-42-2 C 4 H 11 NO 2 105.1356-105.0790-28 C 1) 1.0881 g/cm 3 1)

食糧　その科学と技術　No.46( )

, IARC A ppb ppm, WHOµg/L GC GC GCMS GC MS, d O O O NH 2 Br 2 NEt 3 Br NH 2 NH 2 Br Br GC, [C H NO Br] + m/z [C H NO Br] m/z SIM [C H D NO Br] m/z [C H D NO Br] + m/z Br Br HBr [C H NO Br] + m/z GC -d

CKMS-1202

TOSHIBA Gearmotor PGseries SFseries ギヤモートルの誕生です TOSHIBA Gearmotor PGseries 機種バリエーション kw 0.4 0.75 1.5 2.2 3.7 5.5 7.5 11 15 22 30 37 45 55 PGseries 4 SFseries 4 受け継ぐ東芝INDEX PG 03 SF ギ ヤモ ート ル歴 12 の 14 史をSFseries

<4D F736F F D F90858C6E5F C B B B838B>

Isobutyl alcohol IUPAC 2-methylpropan-1-ol 2--1-2-Methyl-1-Propanol, Isobutanol CH 3 H 3 C OH CAS 78-83-1 C 4 H 10 O log P ow ( C) ( C) (kpa) (g/l) 74.12 74.14 1) -108 2) 108 2) 1.2 2) 87 2) 0.8 2) (74.1214)

ｔｎｂｐ５９－２１＿Ｗｅｂ：Ｐ２／ｋｙ１３２３７９５０９６１０００２９４４

[ GLYCAN ANALYSIS SLUTINS ] [ GLYCAN ANALYSIS SLUTINS ] N N 3 2

N [ GLYCAN ANALYSIS SLUTINS ] [ GLYCAN ANALYSIS SLUTINS ] [ GLYCAN ANALYSIS SLUTINS ] N N 3 2 [ GLYC AN ANALYSIS SLUTINS ] インタクトプロテイン解析のワークフロー 糖タンパク質 Intact mab Mass Check スタンダード LC 分析カラムにインジェクション UV 検出による

Microsoft Word - 14_LCMS_アクリルアミド

3--2-3-Iodo-2-propynyl butylcarbamate (IPBC) Carbamic acid, butyl-, 3-iodo-2-propynyl ester Iodocarb CAS 55406-53-6 C 8 H 12 NO 2 I C (g/cm 3 ) (mmhg) log P ow 281.09 (280.9910) 64 68 1.51 1.57 (20 C)

研修コーナー

l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

パーキンソン病治療ガイドライン2002

2 (FDA) 1 1 A D E K 1 LC UV 15 HPLC 3.5 UHPLC Agilent 12 Infinity LC Agilent 12 Infinity (G1311B) Agilent 12 Infinity (G13E) Agilent 12 Infinity (G131

1 Agilent 12 Infinity 1 Siji Joseph Agilent Technologies, Inc. Bangalore, India 12 1 2 4 5 3 2 1 4 1 12 14 4 2 Agilent 12 Infinity 2 4 5 3 2.5 1. 1.5 2. 2.5 3. 2 (RP-HPLC) Agilent Poroshell EC-C1 Agilent

Microsoft Word - 14_LCMS_アクリルアミド

2,4- (2,4-Dichlorophenoxy) acetic acid 2,4-D 2,4-PA OH O O C A S 94-75-7 C 8 H 6 Cl 2 O 3 Cl Cl ( ) 221. (219.9694) 1) (g/cm 3 ) (25 C) 2) ( C) (.4 mm Hg) 2) ( C) 2) (mmhg) (2 C) 2) (mg/l) (25 C) log P

217/18 217 48 1. 2 AH1pdm9 AH3 B HI AH1pdm9 B AH3 D151GD151N HA 6 AH1pdm9 AH3 B 4 5 5 5 217/18-1 - 217 1 218 3 76 24 well MDCKLLC-MK2HEp-2HeLa RD-18sVero Caco-2 217/18 3 1).75% HI A(H1N1)pdm9 B 3 A(H3N2)

LC/MS/MS によるフェノール類分析 日本ウォーターズ株式会社 2015 Waters Corporation 1 対象化合物 Cl HO HO HO フェノール 2- クロロフェノール (2-CPh) Cl 4-クロロフェノール (4-CPh) HO Cl HO Cl HO Cl Cl 2,4

LC/MS/MS による類分析 日本ウォーターズ株式会社 15 Waters Corporation 1 対象化合物 - クロロ (-CPh) 4-クロロ (4-CPh),4- ジクロロ (,4-DPh),6- ジクロロ (,6-DPh),4,6- トリクロロ (,4,6-TPh) 15 Waters Corporation 1 サンプル調製 ( 検量線 標準液 ) 5 標準溶液添加 (,,4,,,5uL)

MassPREP Mix %TFA 0.1% mg/ml < 70%DFVGYGVKDFVGVGVK 0.1%TFA 0.1% 1 4 mg/ml 1 ml/min UV 20 µl/min MS LC ACQUITY UPLC H-Class Bio

C 18 Matthew A. Lauber, Stephan M. Koza, and Kenneth J. Fountain Waters Corporation, Milford, MA, USA 2 BEH130 C 18 & 0.1%TFA c QC ACQUITY UPLC H-Class Bio XSelect 5 µm XBridge 5 µm MassPREP TM RP Charged

2016/17 P 1 P 8 P13 P18 P23 P28 7 P33 P41 15 P48 P65 GC-MS/MSLC-MS/MS 2016/17 2016 48 1.00 AH3 75.4% HI AH1pdm09 B AH3 D151GD151N HA AH1pdm09 AH3 B 5000 500 2016/17-1 - 2016 2017 78 24 well MDCKLLC-MK2HEp-2HeLa

untitled

ACQUITY UPLC SYNAPT TM G2 HDMS TM 130 2010/3/29 13:00-13:20 2010 Nihon Waters K.K. LC/MS Monoclonal Antibody Aspirin Insulin EPO MW 180 MW 6,000 MW 34,000 MW 147,000 2010 Nihon Waters K.K. 2 1 LC/MS ACQUITY

Bio-No.57/3....

2004. MAR. 3No.57 http://www.wako-chem.co.jp C O N T E N T S 2 Wako Bio Window No.57 MAR.2004 l l l l wako wako l l mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm Wako Bio Window No.57 MAR.2004 3 4 Wako Bio Window

薬物分析法の開発

API5000 TM LC/MS/MS Junichi_Hirokawa@trc.toray.co.jp 1. LC/MS/MS 2. 3. MS/MS 4. 5. API5000 6. 7. 8. 1. LC/MS/MS API 5000 AB/MDS Sciex UPLC API 4000 AB/MDS Sciex Agilent1100 PAL PAL ew wash 4000 QTRAP AB/MDS

% 1% SEM-EDX - X Si Ca SEM-EDX SIMS ppm % M M T 100 % 100 % Ba 1 % 91 % 9 % 9 % 1 % 87 % 13 % 13 % 1 % 64 % 36 % 36 % 1 % 34 46

Review on Hair Analysis in the Wakayama Arsenic Case Jun KAWAI Department of Materials Science and Engineering, Kyoto University Sakyo-ku, Kyoto 606-8501, Japan Received 6 December 2014, Revised 29 December

表 1. HPLC/MS/MS MRM パラメータ 表 2. GC/MS/MS MRM パラメータ 表 1 に HPLC/MS/MS 法による MRM パラメータを示します 1 化合物に対し 定量用のトランジション 確認用のトランジションとコーン電圧を設定しています 表 2 には GC/MS/MS

ACQUITY UPLC TM /MS/MS と GC/MS/MS によるベビーフード中の残留農薬の分析 No. 720007 20001436J 概要 EU の Baby Food Directive 2003/13/EC 1) では ベビーフード中の使用が禁止されている残留農薬について明示しています その濃度が 0.003mg/kg を超えているのか あるいは 0.004-0.008mg/kg

[ cortecs columns ] 可能性の限界に挑戦するµm 以下の ソリッドコアパーティクルカラム

[ cortecs columns ] 可能性の限界に挑戦するµm 以下の ソリッドコアパーティクルカラム C8 C8+ HILIC 究極のカラム効率と 性能を実現する ソリッドコアパーティクル カラム µm 以下のパーティクルの性能を最大 限に発揮させるための独自の研究成果に より ウォーターズは粒子径 µm 以下 の UltraPerformance LC カラムファミリー に 新製品を追加しました.6

Japanese Journal of Pesticide Science 42(1): (2017)

42(1), 203 203 215 (2017) DOI: 10.1584/jpestics.W17-54 1, * 2, ** 3, *** 4, **** 4 1 2 3 4 2017 1 6 Recent data analysis technique in mass spectrometry Takaya Satoh, 1 Kentaro Takahara, 2 Tomoaki Kondo,

第90回日本感染症学会学術講演会抄録（I）

Ł\”ƒ-2005

まえがき

JAAS0012006 1 -------------------------------------------------------------------------------------------------------- 1 2 --------------------------------------------------------------------------------------------------------

固相抽出 ビギナー ズ ガイ ド 日本ウォーターズ株式会社 日本ウォーターズ株式会社 東京本社 東京都品川区北品川 第 5 小池ビル TEL FAX 大阪支社 大阪市淀

固相抽出 ビギナー ズ ガイ ド 日本ウォーターズ株式会社 日本ウォーターズ株式会社 www.waters.com 東京本社 140-0001 東京都品川区北品川 1-3-12 第 5 小池ビル TEL 03-3471-7191 FAX 03-3471-7118 大阪支社 532-0011 大阪市淀川区西中島 5-14-10 サムティ新大阪フロントビル 11F TEL 06-6304-8888 FAX

外因性内分泌攪乱化学物質調査暫定マニュアル（水質、底質、水生生物）

(PCB) 1 ng/l (µg/kg, wet) (µg/kg) 10 (0.01) 1 (0.001) 1 (0.001) 10 (0.01) 1 (0.001) 1 (0.001) 10 (0.01) 1 (0.001) 1 (0.001) 10 (0.01) 1 (0.001) 1 (0.001) 10 (0.01) 1 (0.001) 1 (0.001) 10 (0.01) 1 (0.001)

untitled

HILIC ILIC BEH BEH 009 9 0 5 009 ihon Waters K.K. HILIC HILIC HILIC MS Sub-µm 009 ihon Waters K.K. HILIC? HILIC - Hydrophilic Interaction Chromatography 990 * HILIC (> 80%) *Alpert A. J. J.Chromatogr.

MassHunter Workstation Agilent MassHunter Workstation MS Agilent TOF Q-TOF LC/MS LC/MS GC/MS ICP-MS Agilent MS * MassHunter Workstation LC/MS GC/MS IC

Agilent MassHunter Workstation faster, confident more Our measure is your success. products applications soft ware services MassHunter Workstation Agilent MassHunter Workstation MS Agilent TOF Q-TOF LC/MS

1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915

平成26年度 化学物質分析法開発報告書

N,N- N,N-Dimethylacetamide Acethyldimethylamine CAS 127-19-5 C 4 H 9 NO 87.12 ~ 87.14 87.68413 163-165 C 1) - 18.59 C 2) 1 mg/l 25 C 3) 3.3 hpa 2 C 4) log P ow -.77 2).9429 2/4 C 1) 3.1 4) 1.31E - 8 atm-m

取扱説明書[N-01B]

433 o 434 u 435 i81 p 436 i56 i70 i86 i93 437 438 i66 i63 i15 i52 i57 i36 8 i40 i41 i10 i29 i61 i60 i31 i39 i50 i13 i64 i54 i89 439 440 i89 i20 i58 i68 i90 i65 i55 i76 i75 i77 i18 i84 i51 i94 i17 2 441

JAJP.qxp

Agilent SPE SPE ...3...4...5...6...7...8 OPT...10 SCX...12 SAX...14 DVB...16 PS-DVB...17...18 C18EC...18 C18 ODS...19 C8...20 C2...21...21...22 (CN)...23...23...24 Si-SCX...25 Si-SAX...26...27 Florisil

2 1 7 - TALK ABOUT 21 μ TALK ABOUT 21 Ag As Se 2. 2. 2. Ag As Se 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 Sb Ga Te 2. Sb 2. Ga 2. Te 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4

111-263-本製品をご購入.indd

(DHA) 1 4 6 µg/ml 2,3 4 DHA AOAC 967.22 DHA C UVDHA 22 nm ph 244 265 nm 5 AOAC 994.11 UV UV HPLC Milli Q (Millipore Elix 1 ) Lab-Scan ( ) Fluka () o-

Agilent Syed Salman Lateef Agilent Technologies, Inc. Bangalore, India 8 6 4 2 1.191 1.678 12.46 2.5 5 7.5 1 12.5 ( C) ( ) Agilent Poroshell EC-C18 Agilent 126 Infinity LC (LOD).2 µg/ml 3 9 % Agilent 129

(1.2) T D = 0 T = D = 30 kn 1.2 (1.4) 2F W = 0 F = W/2 = 300 kn/2 = 150 kn 1.3 (1.9) R = W 1 + W 2 = = 1100 N. (1.9) W 2 b W 1 a = 0

1 1 1.1 1.) T D = T = D = kn 1. 1.4) F W = F = W/ = kn/ = 15 kn 1. 1.9) R = W 1 + W = 6 + 5 = 11 N. 1.9) W b W 1 a = a = W /W 1 )b = 5/6) = 5 cm 1.4 AB AC P 1, P x, y x, y y x 1.4.) P sin 6 + P 1 sin 45

2

: / FDA HBsAg HIV 1/2 HCV : QMS : 3.5% IgM () 1.0% H317 - H334 - : : :: : QMS Everolimus : 6.4% (II) H400 - H % SDS QMS EDTA (K 3 ) EDTA (K 2 )

QMS (EVER) 0373852 (QMS) QMS QMS X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X

JAJP.qxp

Agilent 1200 LC Our measure is your success. products applications software services - 4 90,000-20 HPLC - UV-Vis ELSD LC/MS - - Agilent 1200 LC (RRLC) 1 RRLC Agilent 1200 LC 2 2 ZORBAX HT 1.8 µm Poroshell

1 Q A 82% 89% 88% 82% 88% 82%

X線分析の進歩36 別刷

X X X-Ray Fluorescence Analysis on Environmental Standard Reference Materials with a Dry Battery X-Ray Generator Hideshi ISHII, Hiroya MIYAUCHI, Tadashi HIOKI and Jun KAWAI Copyright The Discussion Group

外因性内分泌攪乱化学物質調査暫定マニュアル（水質、底質、水生生物）

N- 1) 2) 1) GC/MS HPLC GC/MS 2) 0.01~0.05µg/l 0.5~50µg/kg GC/MS SIM GC/MS SIM GC/MS SIM a) b) -d 10 -d 10 -d 12 -d 12 c) d) 600 C 4 e) 1 99.999% f) a) b) - IX-1 - c) (ODS) 200-1,000mg 5ml 5ml 5ml d) e)

CRA3689A

AVIC-DRZ90 AVIC-DRZ80 2 3 4 5 66 7 88 9 10 10 10 11 12 13 14 15 1 1 0 OPEN ANGLE REMOTE WIDE SET UP AVIC-DRZ90 SOURCE OFF AV CONTROL MIC 2 16 17 1 2 0 0 1 AVIC-DRZ90 2 3 4 OPEN ANGLE REMOTE SOURCE OFF

研究成果報告書

21 4 25 peroxynitrite angiotensin II ETA MEK/ERK pathway endothelin-1 EDHF (EDHF) EDHF EDHF EDHF 2 [phosphodiesterase 3 (PDE3) cilostazol metformin thromboxane A2 ozagrel eicosapentaenoic acid (EPA) angiotensin

zsj2017 (Toyama) program.pdf

88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf

88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

64 3 g=9.85 m/s 2 g=9.791 m/s 2 36, km ( ) 1 () 2 () m/s : : a) b) kg/m kg/m k

63 3 Section 3.1 g 3.1 3.1: : 64 3 g=9.85 m/s 2 g=9.791 m/s 2 36, km ( ) 1 () 2 () 3 9.8 m/s 2 3.2 3.2: : a) b) 5 15 4 1 1. 1 3 14. 1 3 kg/m 3 2 3.3 1 3 5.8 1 3 kg/m 3 3 2.65 1 3 kg/m 3 4 6 m 3.1. 65 5

Metabolomic Profiling_JA.qxp

LC/MS-TOF LC/Q-TOF GeneSpring MS BLB: Bacterial Leaf Blight Steven Fischer Senior Application Chemist Agilent Technologies Santa Clara, California U.S.A Theodore Sana Senior Research Scientist Agilent

橡A PDF

2 1 MS 300 TRT MS JDI-800 2 g MS Py MS GC Py-GC Py GC 50 Py MS MS Py GC PY-GC 2 JDI-800 MS JDI-800 QP 2000 QP 1000 QP 2000 Fig 1 QP 1000 CI PEG 300 600 423 MS EI CI MS PEG 3 10 g Fig.1 300 600 MS 3 JDI-800

2007　Vol.56　No.6　総説　丸山浩樹

Reprinted from RADIOISOTOPES, Vol.56,.6 June 2007 Japan Radioisotope Association http : //www.jrias.or.jp/ α β α β ε m z α µ µ α m z m z µ µ Curr. Opin. Biotechnol J. Proteome Res Rapid Commun. Mass

x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y)

x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 1 1977 x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y) ( x 2 y + xy 2 x 2 2xy y 2) = 15 (x y) (x + y) (xy

Production of Prostaglandins by the Marine Alga, Gracilaria verrucosa Ichiro NAKAJIMA*1, Kazuhiko SUZAKI*2, and Kenkichi OBA*3 *1 Life Science Researc

Production of Prostaglandins by the Marine Alga, Gracilaria verrucosa Ichiro NAKAJIMA*1, Kazuhiko SUZAKI*2, and Kenkichi OBA*3 *1 Life Science Research Center, Lion Corporation (100, Tajima, Odawara-shi,

Products catalog

2019 2 3 ERZV D 4 ERZV D(V) CS/C1 24 ERZV D(V) 25 27 ERZE A 31 ERZE A(B) CS 46 ERZE E(F) 47 49 53 ERZE A S1 54 ERZE A SC 58 59 63 64 ERZHF 67 ERZVF 70 75 ERZVS 78 ERZC EK (Y) 80 ERZC CK 86 91 ERZA PK 94

RN201506_cs5_0525.indd

ISSN 1349-1229 No.408 June 2015 6 FACE FACE 14 TOPICS 15 10 BSI 3 16 Creativity in Knitting and Crochet 2015 4 4 STUDIO CAC 1942 1965 2008 10 2014 9 URSI Federation of Cosmonautics Medal Booker Gold Medal

HPLC UPLC JP UPLC システムによる 注入回数 3000 回以上 のルーチン製剤分析の実現 分析スループットの向上と使用溶媒量の削減 分析効率の向上 日本薬局方 (JP) は 薬事法第 41 条第一項の規定に基づき医薬品の品質を適性に担保するための公的な規範書であり 多くの医薬品の分析

JP システムによる 注入回数 3000 回以上 のルーチン製剤分析の実現 分析スループットの向上と使用溶媒量の削減 分析効率の向上 日本薬局方 (JP) は 薬事法第 41 条第一項の規定に基づき医薬品の品質を適性に担保するための公的な規範書であり 多くの医薬品の分析法は JP 法を基に開発されます また 一方では最新の技術を積極的に導入することによって 分析法の質を向上すると同時に効率性の向上

サンプル一覧表.PDF

: 1 30 1 : 1 30 : 8662 60 : 4810 30 1 : 19383 90 : 8872 : 6279 : 7098 180 120 90 : 6405 120 : 7234 :3276 60 280 : 8053 180 : 5512 180 : 4368 100 :4462 120 : 4725 120 : 8851 180 : 3024 180 : 3286 150 :

yakugaku-kot.ppt

2009 Masaaki Kotera kot@kuicr.kyoto-u.ac.jp 2 I II / A () B1 () B2 B12 C () D A D () () () () DNA 5- http://www.genome.jp/kegg/pathway.html KEGG PATHWAY Database Xenobiotics biodegradation http://www.genome.jp/kegg/pathway.html

(1) θ a = 5(cm) θ c = 4(cm) b = 3(cm) (2) ABC A A BC AD 10cm BC B D C 99 (1) A B 10m O AOB 37 sin 37 = cos 37 = tan 37

4. 98 () θ a = 5(cm) θ c = 4(cm) b = (cm) () D 0cm 0 60 D 99 () 0m O O 7 sin 7 = 0.60 cos 7 = 0.799 tan 7 = 0.754 () xkm km R km 00 () θ cos θ = sin θ = () θ sin θ = 4 tan θ = () 0 < x < 90 tan x = 4 sin

HILIC UPLC /QTof MS Giuseppe Paglia, 1 James Langridge, 2 and Giuseppe Astarita 3 Center for Systems Biology, University of Iceland, Iceland; 2-3. Wat

HILIC UPLC /QTof MS Giuseppe Paglia, James Langridge, 2 and Giuseppe Astarita 3 Center for Systems Biology, University of Iceland, Iceland; 2-3. Waters Corporation, Manchester, UK and Milford, MA, USA

Ⅱ6.3界面活性剤

6.3 6.3.1 6.3.1 6.3.1.1 (1) (2) a) JIS K 0557 A3 b) JIS K 8891 c) (5g/L) d) (10g/L)JIS K 8576 1g 100mL e) (7+993)JIS K 8951 f) JIS K 8322 g) 0.1g 100mL 30mL 1L 500mL6.8mL 50g 1L h) 1L 500mL6.8mL 50g 1L

Copyright 2009 by Japan Oil Chemists' Society Why Does the Cat Eat a Fish? : The Hypothesis is Based on Lipid Nutrition Hidehiko HIBINO Functional Foo

Copyright 2009 by Japan Oil Chemists' Society Why Does the Cat Eat a Fish? : The Hypothesis is Based on Lipid Nutrition Hidehiko HIBINO Functional Foods Division, NOF CORPORATION, 18-14 Ebisu, 1-Chome,

Agilent OpenLAB CDS ChemStation OpenLAB CDS ChemStation Lab Advisor Secure Workstation Data Store OpenLAB ECM OpenLAB C A P T U R E A N A L Y Z E S H

Agilent OpenLAB CDS ChemStation Rev. C.01.07 Agilent OpenLAB CDS ChemStation OpenLAB CDS ChemStation Lab Advisor Secure Workstation Data Store OpenLAB ECM OpenLAB C A P T U R E A N A L Y Z E S H A R E

Group A (2,5-Dimethoxyphenyl type) 25D-NBMe (1) 25B-NBMe (2) 25I-NBMe (3) 25C-NBF () 25B-NBF (5) Group B (Benzofuran-2-yl type) Group C (-Alkoxy-3,5-d

3 * * * * * Analytical data of designer drugs of synthetic phenethylamines Ryosuke SASAKI*, Miho KAT*, Tsuyoshi MATSUMT*, Akira UDAGAWA* and Ryuichi MATSUZAKI* *Tokyo Customs Laboratory 2-7-11, Aomi, Koto-ku,

untitled

( ) c a sin b c b c a cos a c b c a tan b a b cos sin a c b c a ccos b csin (4) Ma k Mg a (Gal) g(98gal) (Gal) a max (K-E) kh Zck.85.6. 4 Ma g a k a g k D τ f c + σ tanφ σ 3 3 /A τ f3 S S τ A σ /A σ /A

橡J0021-1.PDF

1 1950 60 PE PP PVD C PVC FT-lR DS C XRF GC LC 1 HS GC 2 2 1 2 1 GC GC 80 5 3 3 200 2 PVC 2 3 2 2 4 JHS 100 5 10ml GC 5 JHS-100 3 3 1 JHS 100A QP 5000 GC MS 6 1 1 TC-WAX 0.25mm 60m 40 180 5 /min--- 280

21 1113 127 23 21 12 TEL 0762251341 1 44 2 3 20 66 1 6 10 24 36 50 58 80 100 10 104 11 118 12 130 13 144 14 150 15 184 16 186 17 194 18 202 19 204 20 230 21 242 22 254 23 262 24 266 25 268 26 270 271

A(6, 13) B(1, 1) 65 y C 2 A(2, 1) B( 3, 2) C 66 x + 2y 1 = 0 2 A(1, 1) B(3, 0) P 67 3 A(3, 3) B(1, 2) C(4, 0) (1) ABC G (2) 3 A B C P 6

1 1 1.1 64 A6, 1) B1, 1) 65 C A, 1) B, ) C 66 + 1 = 0 A1, 1) B, 0) P 67 A, ) B1, ) C4, 0) 1) ABC G ) A B C P 64 A 1, 1) B, ) AB AB = 1) + 1) A 1, 1) 1 B, ) 1 65 66 65 C0, k) 66 1 p, p) 1 1 A B AB A 67

14 : : : : : : 00 LC/MS/MS 1, : : 00 Novel strategies and applications of enhanced shotgun lipidomics for

1 9 6 1 [ 講堂 ]2F 8 : 45-8 : 55 8 : 55-11 : 00 1 S1-1 1,2 1 2 S1-2 1 1 2 3 1 2 3 S1-3 1,2 1,2 1 2 S1-4 MALDI 1 2 1 2 S1-5 12 : 00-13 : 00 1 LS1 12 14 : 00-14 : 40 14 : 40-15 : 10 15 : 10-16 : 00 LC/MS/MS

8 1. 2. 3. 4. 5. 6. 7. 8. 1... 1 1.1.... 1 1.1.1.... 1 1.1.2.... 6 1.2.... 8 1.2.1.... 8 1.2.2....11 1.2.3.... 12 1.2.4.... 12 1.2.5.... 12 1.2.6.... 13 1.2.7.... 14 1.3.... 15 1.3.1.... 15 1.3.2....

linearal1.dvi

19 4 30 I 1 1 11 1 12 2 13 3 131 3 132 4 133 5 134 6 14 7 2 9 21 9 211 9 212 10 213 13 214 14 22 15 221 15 222 16 223 17 224 20 3 21 31 21 32 21 33 22 34 23 341 23 342 24 343 27 344 29 35 31 351 31 352

ヒト血漿中オキシステロールの高感度分析法

High sensitive determination of oxysterols in human plasma using gas chromatography-mass spectrometry (GC-MS) Saori Nakagawa and Susumu Yamato Oxysterols, cholesterol oxidation products, have been important

62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC -

1 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] g/dl A 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - [ ] Point ~ 62 [ ] [ ] [ ] [ ] [ ] [ ] / /

L26-XB07, L32-XB07 TEL 0570 (07) 0101

untitled

PGF 17 6 1 11 1 12 1 2 21 2 22 2 23 3 1 3 1 3 2 3 3 3 4 3 5 4 6 4 2 4 1 4 2 4 3 4 4 4 5 5 3 5 1 5 2 5 5 5 5 4 5 1 5 2 5 3 6 5 6 1 6 2 6 6 6 24 7 1 7 1 7 2 7 3 7 4 8 2 8 1 8 2 8 3 9 4 9 5 9 6 9 3 9 1 9

ソリッドコアUHPLCカラムとUHPLCシステム、質量分析計を利用した違法薬物の高速スクリーニング分析

UHPLCUHPLC Application Note CC2999 Vanquish Accucoreopiates benzodiazepines amphetamines Thermo Scientific Accucore Vanquish C18 UHPLC1.5 m Vanquish UHPLC 47 UHPLC Vanquish UHPLC Accucore Vanquish UHPLC

<4D F736F F D209A6291A794AD8DEC88E397C38AD68C578ED22E646F63>

医療関係者の皆様へ 1. 早期発見と早期対応 予防のポイント 成人気管支喘息の中にはアラキドン酸シクロオキシゲナーゼ (COX) 阻害作用をもつアスピリン様薬物 = 非ステロイド性抗炎症薬 (non-steroidal antiinflammatory drugs, NSAIDs) を投与されることにより 喘息発作を主体とする激しい過敏反応が誘発される患者群が存在する 1) 一般にアスピリン喘息と呼称されるが

本文／ＹＡ４２７８Ｉ

pp. D- D-DAO DAO D- D- D- D- o- DAO-D- D-DAO DAO Hans Krebs FAD X DAO DAO DAO D- Structure and reaction mechanism of D-amino acid oxidase Yasuzo Nishina School of Health Sciences, Kumamoto University,

TS02_TS06_TS09_UserManual

Leica FlexLine TS02/TS06/TS09 FlexLine, 2 FlexLine, 3 FlexLine, 4 TSOX_135 FlexLine, 5 FlexLine, 6 FlexLine, 7 FlexLine, 8 FlexLine, 9 FlexLine, 10 FlexLine, 11 FlexLine, 12 TSOX_001 a c Flex Office b

DCV ACV DCI ACI DCV ACV DCI ACI DCV ACV DCI ACI DCV ACV DCI ACI Excel JIS Microsoft Excel I-V START I-V Excel I-V JIS C-8913 Excel Excel I-V ISC Isc J

Agilent Technologies B2900A Microsoft Excel I-V GP-IB Agilent SMU B2900A Series DC 6V/3.03A 21V/1.515A 210V/0.105A JIS 1 2 DARK I-V I-V DCV ACV DCI ACI DCV ACV DCI ACI DCV ACV DCI ACI DCV ACV DCI ACI Excel